Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Dexamethasone (excluding Implant), (obg) Atc S01ba01 For The Period 01.01.2025 31.12.2026 2026-11-05
Germany Open Framework Agreement On Drug Discounts According To § 130a Para. 8 Sgb V With The Possibility Of Joining At Any Time, So-called Approval Model 202501 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Apremilast, (obo) Atc L04aa32 For The Period 01.01.2025 31.12.2026 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Sevelamer Hydrochloride, (obg) Atc V03ae02 For The Period 01.01.2025 - 31.12.2026 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Allergen Extract From Tree Pollen (exclusively In The Dafo Pump Solution), Atc V01aa05 F. D. Z. 01.01.25 31.12.26 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Ingredient Dexamethasone (excluding Implant), (obg) Atc S01ba01 For The Period 01.01.2025 - 31.12.2026 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb V) For The Active Ingredient Allergen Extract From Tree Pollen (exclusively In The Dafo Pump Solution), Atc V01aa05 For The Period From 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Rotigotine, (obg) Atc N04bc09 For The Period 01.01.2025 - 31.12.2026 Medicines 2026-11-05
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Para. 8 Sgb V With The Active Ingredient Adalimumab 2026-11-10
Germany Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Adalimumab 2026-11-10
Whats app